We present three small biotech stocks, which according to Wall Street analysts, have upside potential for 2025.

Bird flu has emerged as a critical public health concern in California, with Governor Gavin Newsom declaring a state of ...

Let's explore two healthcare sector dividend stocks that could make a fantastic addition to your ... Pfizer has struggled in ...

Moderna 's ( MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock ...

After falling off their perch in the last few months of 2024, European healthcare stocks head into a new year facing the ...

Argus downgraded Moderna (MRNA) to Hold from Buy without a price target The firm sees limited upside for the stock over the next 12 months as ...

Thermo Fisher perfectly rode the tidal wave of demand for health care that came during the pandemic. The company experienced ...

Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the ...

The S&P 500 slid 0.4% on Tuesday, Sept. 17, as stocks faltered ahead of Wednesday's Federal Reserve's interest rate ...

Pfizer shares rallied after the drugmaker's 2025 guidance met Wall Street expectations, cheering shareholders as the company faces pressure to improve performance. The company forecast next year’s ...

Fox News senior medical contributor Dr. Marc Siegel joins ‘America’s Newsroom’ to discuss Trump health secretary pick Robert ...